The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Babineau, Kenneth Bruce
    Vice President Cfo born in January 1970
    Individual (4 offsprings)
    Officer
    2022-11-01 ~ now
    OF - Director → CIF 0
  • 2
    23, Hospital Fields Road, York, England
    Active Corporate (2 parents, 1 offspring)
    Equity (Company account)
    -3,246,944 GBP2023-12-31
    Person with significant control
    2021-01-01 ~ now
    PE - Ownership of shares – 75% or more → CIF 0
Ceased 23
  • 1
    Napier, Peter
    Sales & Marketing Director born in May 1965
    Individual (2 offsprings)
    Officer
    2005-08-02 ~ 2007-03-01
    OF - Director → CIF 0
  • 2
    Wilson, Mark Richard
    Company Director born in January 1960
    Individual
    Officer
    1999-09-28 ~ 2001-09-13
    OF - Director → CIF 0
    Wilson, Mark Richard
    Individual
    Officer
    1999-10-12 ~ 2001-09-13
    OF - Secretary → CIF 0
  • 3
    Hirst, Judith Mary
    Administrator born in April 1954
    Individual
    Officer
    1999-07-20 ~ 1999-09-28
    OF - Director → CIF 0
  • 4
    Goodwin, Lee, Dr
    Director, Clinical Trial Operations born in February 1978
    Individual
    Officer
    2018-03-13 ~ 2018-11-25
    OF - Director → CIF 0
  • 5
    Hern, Warren
    Ceo born in January 1952
    Individual (1 offspring)
    Officer
    2010-09-23 ~ 2014-11-01
    OF - Director → CIF 0
  • 6
    Carges Jr, Joseph Stephen
    Cfo born in January 1954
    Individual
    Officer
    2009-03-04 ~ 2011-06-24
    OF - Director → CIF 0
    Carges Jr, Joseph Stephen
    Cfo
    Individual
    Officer
    2009-03-04 ~ 2011-06-24
    OF - Secretary → CIF 0
  • 7
    Mcateer, Stephen Gerald
    Managing Dir born in August 1953
    Individual (1 offspring)
    Officer
    1999-07-20 ~ 2005-08-02
    OF - Director → CIF 0
    Mcateer, Stephen Gerald
    Managing Dir
    Individual (1 offspring)
    Officer
    1999-07-20 ~ 1999-10-12
    OF - Secretary → CIF 0
  • 8
    Dickinson, Paul Michael
    Chartered Accountant born in April 1960
    Individual (3 offsprings)
    Officer
    1999-10-22 ~ 2000-10-04
    OF - Director → CIF 0
    2001-12-18 ~ 2005-08-02
    OF - Director → CIF 0
    Dickinson, Paul Michael
    Individual (3 offsprings)
    Officer
    2002-05-13 ~ 2005-08-02
    OF - Secretary → CIF 0
  • 9
    Waite, Charles Francis Simon
    Chief Financial Officer born in January 1967
    Individual (5 offsprings)
    Officer
    2018-03-13 ~ 2018-08-28
    OF - Director → CIF 0
  • 10
    Logan, Elena
    Vice President born in October 1963
    Individual
    Officer
    2009-03-04 ~ 2010-09-24
    OF - Director → CIF 0
  • 11
    D'souza, John, Dr
    Managing Director born in January 1943
    Individual (1 offspring)
    Officer
    2010-09-23 ~ 2015-11-12
    OF - Director → CIF 0
  • 12
    Singh, Jaspal
    Director born in September 1965
    Individual (1 offspring)
    Officer
    2000-10-04 ~ 2005-08-02
    OF - Director → CIF 0
    Singh, Jaspal
    Finance Director
    Individual (1 offspring)
    Officer
    2001-09-13 ~ 2002-05-13
    OF - Secretary → CIF 0
  • 13
    Panzarella, Angela
    President-Acm Medical Lab. born in February 1958
    Individual
    Officer
    2011-08-16 ~ 2015-11-12
    OF - Director → CIF 0
  • 14
    Glenz, Arthur Edward
    Chief Executive born in May 1949
    Individual
    Officer
    2009-03-04 ~ 2010-05-14
    OF - Director → CIF 0
  • 15
    Joyce, Jonathan Mark
    Finance Director born in January 1970
    Individual (5 offsprings)
    Officer
    2005-10-25 ~ 2009-03-04
    OF - Director → CIF 0
    Joyce, Jonathan Mark
    Finance Director
    Individual (5 offsprings)
    Officer
    2005-10-25 ~ 2009-03-04
    OF - Secretary → CIF 0
  • 16
    Foley, John Vincent
    Executive Vp Strategy & Business Development born in April 1960
    Individual
    Officer
    2017-11-09 ~ 2019-03-15
    OF - Director → CIF 0
    Mr John Vincent Foley
    Born in April 1960
    Individual
    Person with significant control
    2017-11-09 ~ 2019-03-15
    PE - Has significant influence or control → CIF 0
  • 17
    Ramachandran, Gita
    Chief Finance Officer born in August 1953
    Individual
    Officer
    2015-11-12 ~ 2017-10-13
    OF - Director → CIF 0
    Ms Gita Ramachandron
    Born in August 1953
    Individual
    Person with significant control
    2016-07-01 ~ 2017-11-23
    PE - Has significant influence or control as a member of a firm → CIF 0
  • 18
    Boxall, Jeremy Mark
    Biomedical Scientist born in June 1960
    Individual (3 offsprings)
    Officer
    2005-01-01 ~ 2018-03-13
    OF - Director → CIF 0
    Boxall, Jeremy Mark
    Managing Director
    Individual (3 offsprings)
    Officer
    2005-08-02 ~ 2005-10-25
    OF - Secretary → CIF 0
    Mr Jeremy Mark Boxall
    Born in June 1960
    Individual (3 offsprings)
    Person with significant control
    2016-07-01 ~ 2018-03-13
    PE - Has significant influence or control as a member of a firm → CIF 0
  • 19
    Wright, Brian Hopkins
    Chief Executive born in November 1980
    Individual (2 offsprings)
    Officer
    2019-03-15 ~ 2022-11-01
    OF - Director → CIF 0
    Mr Brian Hopkins Wright
    Born in November 1980
    Individual (2 offsprings)
    Person with significant control
    2019-03-15 ~ 2020-04-28
    PE - Right to appoint or remove directors → CIF 0
  • 20
    Singh, Sam Sarbjit
    It Director born in October 1970
    Individual (2 offsprings)
    Officer
    2005-08-02 ~ 2012-03-26
    OF - Director → CIF 0
  • 21
    Collier House, 163-169 Brompton Road, London
    Dissolved Corporate (1 parent, 15 offsprings)
    Officer
    1999-07-20 ~ 1999-07-20
    PE - Nominee Secretary → CIF 0
  • 22
    ACM GLOBAL CENTRAL LABORATORY OPERATIONS LIMITED
    23, 23 Hospital Fields Road, York, England
    Active Corporate (2 parents, 1 offspring)
    Equity (Company account)
    -3,246,944 GBP2023-12-31
    Person with significant control
    2020-04-28 ~ 2021-05-12
    PE - Ownership of shares – 75% or more → CIF 0
  • 23
    Collier House, 163-169 Brompton Road, London
    Corporate (1 offspring)
    Officer
    1999-07-20 ~ 1999-07-20
    PE - Nominee Director → CIF 0
parent relation
Company in focus

ACM GLOBAL CENTRAL LABORATORY LIMITED

Previous name
PIVOTAL LABORATORIES LIMITED - 2009-03-24
Standard Industrial Classification
74909 - Other Professional, Scientific And Technical Activities N.e.c.
Brief company account
Par Value of Share
Class 1 ordinary share
102023-01-01 ~ 2023-12-31
Turnover/Revenue
24,225,167 GBP2023-01-01 ~ 2023-12-31
19,962,856 GBP2022-01-01 ~ 2022-12-31
Cost of Sales
16,852,496 GBP2023-01-01 ~ 2023-12-31
15,535,999 GBP2022-01-01 ~ 2022-12-31
Gross Profit/Loss
7,372,671 GBP2023-01-01 ~ 2023-12-31
4,426,857 GBP2022-01-01 ~ 2022-12-31
Administrative Expenses
5,878,854 GBP2023-01-01 ~ 2023-12-31
3,338,278 GBP2022-01-01 ~ 2022-12-31
Operating Profit/Loss
3,153,330 GBP2023-01-01 ~ 2023-12-31
1,968,440 GBP2022-01-01 ~ 2022-12-31
Other Interest Receivable/Similar Income (Finance Income)
185,776 GBP2023-01-01 ~ 2023-12-31
167,235 GBP2022-01-01 ~ 2022-12-31
Profit/Loss on Ordinary Activities Before Tax
3,339,106 GBP2023-01-01 ~ 2023-12-31
2,135,675 GBP2022-01-01 ~ 2022-12-31
Tax/Tax Credit on Profit or Loss on Ordinary Activities
723,072 GBP2023-01-01 ~ 2023-12-31
355,160 GBP2022-01-01 ~ 2022-12-31
Profit/Loss
2,616,034 GBP2023-01-01 ~ 2023-12-31
1,780,515 GBP2022-01-01 ~ 2022-12-31
Comprehensive Income/Expense
2,616,034 GBP2023-01-01 ~ 2023-12-31
1,780,515 GBP2022-01-01 ~ 2022-12-31
Property, Plant & Equipment
1,529,052 GBP2023-12-31
1,721,226 GBP2022-12-31
Fixed Assets - Investments
2 GBP2023-12-31
2 GBP2022-12-31
Fixed Assets
1,529,054 GBP2023-12-31
1,721,228 GBP2022-12-31
Total Inventories
616,249 GBP2023-12-31
767,950 GBP2022-12-31
Debtors
12,986,210 GBP2023-12-31
12,454,319 GBP2022-12-31
Cash at bank and in hand
4,056,059 GBP2023-12-31
1,848,335 GBP2022-12-31
Current Assets
17,658,518 GBP2023-12-31
15,070,604 GBP2022-12-31
Creditors
Current
8,309,341 GBP2023-12-31
8,548,554 GBP2022-12-31
Net Current Assets/Liabilities
9,349,177 GBP2023-12-31
6,522,050 GBP2022-12-31
Total Assets Less Current Liabilities
10,878,231 GBP2023-12-31
8,243,278 GBP2022-12-31
Net Assets/Liabilities
10,691,750 GBP2023-12-31
8,075,716 GBP2022-12-31
Equity
Called up share capital
58,630 GBP2023-12-31
58,630 GBP2022-12-31
58,630 GBP2021-12-31
Share premium
476,501 GBP2023-12-31
476,501 GBP2022-12-31
476,501 GBP2021-12-31
Capital redemption reserve
30,100 GBP2023-12-31
30,100 GBP2022-12-31
30,100 GBP2021-12-31
Retained earnings (accumulated losses)
10,126,519 GBP2023-12-31
7,510,485 GBP2022-12-31
5,729,970 GBP2021-12-31
Equity
10,691,750 GBP2023-12-31
8,075,716 GBP2022-12-31
6,295,201 GBP2021-12-31
Comprehensive Income/Expense
Retained earnings (accumulated losses)
2,616,034 GBP2023-01-01 ~ 2023-12-31
1,780,515 GBP2022-01-01 ~ 2022-12-31
Wages/Salaries
5,340,309 GBP2023-01-01 ~ 2023-12-31
4,595,468 GBP2022-01-01 ~ 2022-12-31
Social Security Costs
595,861 GBP2023-01-01 ~ 2023-12-31
528,484 GBP2022-01-01 ~ 2022-12-31
Pension & Other Post-employment Benefit Costs/Other Pension Costs
328,899 GBP2023-01-01 ~ 2023-12-31
242,892 GBP2022-01-01 ~ 2022-12-31
Staff Costs/Employee Benefits Expense
6,265,069 GBP2023-01-01 ~ 2023-12-31
5,366,844 GBP2022-01-01 ~ 2022-12-31
Average Number of Employees
1502023-01-01 ~ 2023-12-31
1332022-01-01 ~ 2022-12-31
Property, Plant & Equipment - Depreciation Expense
Owned assets
578,298 GBP2023-01-01 ~ 2023-12-31
639,379 GBP2022-01-01 ~ 2022-12-31
Current Tax for the Period
704,153 GBP2023-01-01 ~ 2023-12-31
187,598 GBP2022-01-01 ~ 2022-12-31
Tax Expense/Credit at Applicable Tax Rate
785,358 GBP2023-01-01 ~ 2023-12-31
405,778 GBP2022-01-01 ~ 2022-12-31
Intangible Assets - Gross Cost
Net goodwill
344,231 GBP2022-12-31
Intangible Assets - Accumulated Amortisation & Impairment
Net goodwill
344,231 GBP2022-12-31
Property, Plant & Equipment - Gross Cost
Improvements to leasehold property
2,031,396 GBP2023-12-31
2,024,047 GBP2022-12-31
Plant and equipment
1,931,486 GBP2023-12-31
2,493,400 GBP2022-12-31
Furniture and fittings
134,158 GBP2023-12-31
171,786 GBP2022-12-31
Property, Plant & Equipment - Gross Cost
4,256,037 GBP2023-12-31
4,689,233 GBP2022-12-31
Property, Plant & Equipment - Disposals
Plant and equipment
-772,587 GBP2023-01-01 ~ 2023-12-31
Furniture and fittings
-48,492 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Disposals
-821,079 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Gross Cost
Computers
158,997 GBP2023-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Improvements to leasehold property
1,568,284 GBP2023-12-31
1,332,649 GBP2022-12-31
Plant and equipment
1,046,518 GBP2023-12-31
1,525,825 GBP2022-12-31
Furniture and fittings
112,183 GBP2023-12-31
109,533 GBP2022-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
2,726,985 GBP2023-12-31
2,968,007 GBP2022-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Improvements to leasehold property
235,635 GBP2023-01-01 ~ 2023-12-31
Plant and equipment
291,521 GBP2023-01-01 ~ 2023-12-31
Furniture and fittings
51,142 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
578,298 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Decrease in depreciation and impairment related to disposals
Plant and equipment
-770,828 GBP2023-01-01 ~ 2023-12-31
Furniture and fittings
-48,492 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Decrease in depreciation and impairment related to disposals
-819,320 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment
Improvements to leasehold property
463,112 GBP2023-12-31
691,398 GBP2022-12-31
Plant and equipment
884,968 GBP2023-12-31
967,575 GBP2022-12-31
Furniture and fittings
21,975 GBP2023-12-31
62,253 GBP2022-12-31
Computers
158,997 GBP2023-12-31
Investments in Group Undertakings
Cost valuation
2 GBP2022-12-31
Investments in Group Undertakings
2 GBP2023-12-31
2 GBP2022-12-31
Merchandise
306,430 GBP2023-12-31
385,007 GBP2022-12-31
Trade Debtors/Trade Receivables
Current
1,733,388 GBP2023-12-31
2,223,378 GBP2022-12-31
Amounts Owed by Group Undertakings
Current
3,051,562 GBP2023-12-31
1,528,516 GBP2022-12-31
Other Debtors
Current
4,578 GBP2023-12-31
1,168 GBP2022-12-31
Amount of corporation tax that is recoverable
Current
925,581 GBP2023-12-31
1,262,499 GBP2022-12-31
Amount of value-added tax that is recoverable
Current
27,904 GBP2023-12-31
20,883 GBP2022-12-31
Prepayments/Accrued Income
Current
1,287,277 GBP2023-12-31
1,811,006 GBP2022-12-31
Debtors
Current, Amounts falling due within one year
7,030,290 GBP2023-12-31
6,847,450 GBP2022-12-31
Trade Creditors/Trade Payables
Current
1,485,918 GBP2023-12-31
1,718,863 GBP2022-12-31
Amounts owed to group undertakings
Current
5,500,002 GBP2023-12-31
5,500,002 GBP2022-12-31
Other Taxation & Social Security Payable
Current
149,826 GBP2023-12-31
127,991 GBP2022-12-31
Other Creditors
Current
55,203 GBP2023-12-31
78,925 GBP2022-12-31
Accrued Liabilities/Deferred Income
Current
1,118,392 GBP2023-12-31
1,122,773 GBP2022-12-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
464,190 GBP2023-12-31
496,211 GBP2022-12-31
Between one and five year
1,279,661 GBP2023-12-31
1,312,114 GBP2022-12-31
More than five year
109,395 GBP2023-12-31
30,714 GBP2022-12-31
All periods
1,853,246 GBP2023-12-31
1,839,039 GBP2022-12-31
Deferred Tax Liabilities
Accelerated tax depreciation
186,481 GBP2023-12-31
167,562 GBP2022-12-31
Amounts set aside to cover potential liabilities or losses
Deferred taxation
186,481 GBP2023-12-31
167,562 GBP2022-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
586,300 shares2023-12-31
Related profiles found in government register
  • ACM GLOBAL CENTRAL LABORATORY LIMITED
    Info
    PIVOTAL LABORATORIES LIMITED - 2009-03-24
    Registered number 03809941
    23 Hospital Fields Road, York, North Yorkshire YO10 4DZ
    Private Limited Company incorporated on 1999-07-20 (25 years 11 months). The company status is Active.
    The last date of confirmation statement was made at 2024-05-25
    CIF 0
  • ACM GLOBAL CENTRAL LABORATORY LIMITED
    S
    Registered number 03809941
    23, Hospital Fields Road, York, England, YO10 4DZ
    Private Limited Company in England & Wales, United Kingdom
    CIF 1
    Private Limited Company in England And Wales, United Kingdom
    CIF 2
  • ACM GLOBAL CENTRAL LABORATORY LIMITED
    S
    Registered number 03809941
    23, Hospital Fields Road, York, North Yorkshire, United Kingdom, YO10 4DZ
    Private Limited Company in Companies House, England And Wales
    CIF 3
(more)
child relation
Offspring entities and appointments
Active 4
  • 1
    ABS LABORATORIES LIMITED - 2020-12-02
    3rd Floor Westfield House 60 Charter Row, Sheffield
    Dissolved Corporate (2 parents)
    Equity (Company account)
    Retained earnings (accumulated losses)
    598,512 GBP2018-12-31
    Person with significant control
    2018-06-12 ~ dissolved
    CIF 1 - Ownership of shares – 75% or more → OE
  • 2
    ABS LABORATORIES HOLDINGS LIMITED - 2020-12-02
    3rd Floor Westfield House 60 Charter Row, Sheffield
    Dissolved Corporate (2 parents)
    Equity (Company account)
    1,000,000 GBP2018-12-31
    Person with significant control
    2018-06-12 ~ dissolved
    CIF 2 - Ownership of shares – 75% or more → OE
    CIF 2 - Ownership of voting rights - 75% or more → OE
  • 3
    LABORATORIES ABS YORK HOLDINGS LIMITED - 2020-12-03
    23 Hospital Fields Road, York, North Yorkshire, United Kingdom
    Active Corporate (2 parents)
    Equity (Company account)
    1 GBP2023-12-31
    Person with significant control
    2020-11-24 ~ now
    CIF 3 - Ownership of shares – 75% or more → OE
    CIF 3 - Ownership of voting rights - 75% or more → OE
    CIF 3 - Right to appoint or remove directors → OE
  • 4
    LABORATORIES ABS YORK LIMITED - 2020-12-03
    23 Hospital Fields Road, York, North Yorkshire, United Kingdom
    Active Corporate (2 parents)
    Equity (Company account)
    1 GBP2023-12-31
    Person with significant control
    2020-11-24 ~ now
    CIF 4 - Ownership of shares – 75% or more → OE
    CIF 4 - Ownership of voting rights - 75% or more → OE
    CIF 4 - Right to appoint or remove directors → OE

qrcode

Privacy notice

Terms and conditions

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.